Urinary Tumor Markers for Bladder Cancer
Customize your policy alerts
Sign up for Blue Cross Blue Shield - New Mexico Policy RPLAB038 alerts
Get alerted when Policy RPLAB038 changes without checking for updates manually.
Monitor payer policy activity
Defines BCBSNM reimbursement stance for urinary tumor marker tests for bladder cancer diagnosis and surveillance, and identifies specific situations where tests are reimbursable or not; applies to providers submitting claims to Blue Cross Blue Shield - New Mexico.
Reimbursement Information #1 and #2 were edited for clarity.
References were revised during the most recent update.
Several CPT/HCPCS codes (0012M, 0013M, 0363U, 0420U, 0452U, 0465U, 0549U) were removed in a prior update.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.